Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
296.50
+2.92 (0.99%)
At close: Jun 6, 2025, 4:00 PM
298.00
+1.50 (0.51%)
After-hours: Jun 6, 2025, 4:48 PM EDT
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $8.52 billion as of June 6, 2025. Its market cap has decreased by -30.66% in one year.
Market Cap
8.52B
Enterprise Value
8.23B
1-Year Change
-30.66%
Ranking
Category
Stock Price
$296.50
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $8.52B, an increase of 673.52%. That is a compound annual growth rate of 26.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 8.52B | -17.47% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.52B |
| Johnson & Johnson | 368.66B |
| AbbVie | 330.92B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.49B |
| Abbott Laboratories | 231.33B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |